ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Jdlc
|
100 |
23K |
18 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
100
|
23K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Jdlc
|
2.9K |
1.0M |
40 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
40
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jdlc
|
2.2K |
749K |
13 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
2.2K
|
749K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jdlc
|
2.2K |
749K |
10 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
2.2K
|
749K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Jdlc
|
508 |
126K |
29 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
126K
|
29
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Jdlc
|
21K |
7.4M |
17 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
21K
|
7.4M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Jdlc
|
508 |
126K |
21 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
126K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Jdlc
|
508 |
126K |
20 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
126K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Jdlc
|
508 |
126K |
20 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
126K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Jdlc
|
508 |
126K |
26 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
508
|
126K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: EMD AML MDS Trial Expands to Europe
|
|
Jdlc
|
94 |
32K |
40 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
94
|
32K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jdlc
|
2.2K |
749K |
11 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
2.2K
|
749K
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
37 |
29/05/23 |
29/05/23 |
General
|
11K
|
3.8M
|
37
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
16 |
26/05/23 |
26/05/23 |
General
|
11K
|
3.8M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Jdlc
|
1.8K |
632K |
48 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
1.8K
|
632K
|
48
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
33 |
09/05/23 |
09/05/23 |
General
|
11K
|
3.8M
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
Jdlc
|
187 |
69K |
11 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
187
|
69K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
Jdlc
|
227 |
85K |
63 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
227
|
85K
|
63
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
13 |
14/04/23 |
14/04/23 |
General
|
11K
|
3.8M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Jdlc
|
239 |
97K |
29 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
239
|
97K
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases cardioprotection market potential data
|
|
Jdlc
|
239 |
97K |
31 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
239
|
97K
|
31
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
12 |
28/03/23 |
28/03/23 |
General
|
11K
|
3.8M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Jdlc
|
196 |
70K |
42 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
196
|
70K
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
Jdlc
|
187 |
69K |
16 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
187
|
69K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: New Collaboration to Understand Zantrene Cardioprotection
|
|
Jdlc
|
88 |
32K |
6 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
88
|
32K
|
6
|
|
ASX - By Stock
|
ILA |
Re:
Ann: ILA submits IND to US FDA for Phase 2a PEACH clinical trial
|
|
Jdlc
|
9 |
3.3K |
6 |
28/12/22 |
28/12/22 |
ASX - By Stock
|
9
|
3.3K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
2 |
29/11/22 |
29/11/22 |
General
|
11K
|
3.8M
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
3 |
28/11/22 |
28/11/22 |
General
|
11K
|
3.8M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
16 |
20/11/22 |
20/11/22 |
General
|
11K
|
3.8M
|
16
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
4 |
20/11/22 |
20/11/22 |
General
|
11K
|
3.8M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
58 |
20/11/22 |
20/11/22 |
General
|
11K
|
3.8M
|
58
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
62 |
12/11/22 |
12/11/22 |
General
|
11K
|
3.8M
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Develops Improved IV Formulation of Zantrene
|
|
Jdlc
|
90 |
35K |
51 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
90
|
35K
|
51
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives Governance Approval for AML EMD & MDS Trial
|
|
Jdlc
|
96 |
37K |
14 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
96
|
37K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives Governance Approval for AML EMD & MDS Trial
|
|
Jdlc
|
96 |
37K |
5 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
96
|
37K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
Jdlc
|
215 |
73K |
6 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
215
|
73K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Receives Governance Approval for AML EMD & MDS Trial
|
|
Jdlc
|
96 |
37K |
18 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
96
|
37K
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Jdlc
|
11K |
3.8M |
9 |
17/02/22 |
17/02/22 |
General
|
11K
|
3.8M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Jdlc
|
2.9K |
1.0M |
38 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Jdlc
|
1.8K |
632K |
11 |
19/12/21 |
19/12/21 |
ASX - By Stock
|
1.8K
|
632K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Jdlc
|
2.2K |
749K |
39 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
2.2K
|
749K
|
39
|
|
ASX - By Stock
|
RAC |
Re:
Ann: SPP Closing Deadline Reminder & Investor Briefing Recording
|
|
Jdlc
|
82 |
28K |
62 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
82
|
28K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Breakthrough Zantrene Heart Protection Discovery
|
|
Jdlc
|
366 |
122K |
40 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
366
|
122K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Ann: AGM Presentations
|
|
Jdlc
|
82 |
26K |
15 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
82
|
26K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: AGM Presentations
|
|
Jdlc
|
82 |
26K |
16 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
82
|
26K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: AGM Presentations
|
|
Jdlc
|
82 |
26K |
12 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
82
|
26K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Breakthrough Zantrene Heart Protection Discovery
|
|
Jdlc
|
366 |
122K |
25 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
366
|
122K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Breakthrough Zantrene Heart Protection Discovery
|
|
Jdlc
|
366 |
122K |
43 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
366
|
122K
|
43
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Annual General Meeting MD Presentation
|
|
Jdlc
|
3 |
1.1K |
4 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
3
|
1.1K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Jdlc
|
1.8K |
632K |
15 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
1.8K
|
632K
|
15
|
|